gip/glp 1-agonist tirzepatide Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research GLP-1/GIP dual agonist tirzepatide normalizes
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12


























